跳至主要内容
临床试验/NCT03611348
NCT03611348Unknown2 期

Effectiveness of Microneedling and Topical Latanoprost in Treatment of Acrofacial Vitiligo

Sohag University0 个研究点目标入组 70 人开始时间: 2018年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
70
主要终点
Improvement in VASI score

研究概览

简要总结

To compare efficacy of topical latanoprost preceded by microneedling versus topical latanoprost alone in treatment of acrofacial vitiligo.

详细描述

patients meeting inclusion and exclusion criteria presented to Dermatology Outpatient Clinic, Sohag University Hospital will be enrolled in the study after obtaining a written consent from them. Full history will be obtained and meticulous examination will be carried out. Patients will be randomly divided into 2 groups, one group will receive topical latanoprost with microneedling, and the other one will receive topical latabnoprost alone.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acrofacial stable vitiligo for 6 months duration (without new lesions appearance or change in size of the existing lesions).

排除标准

  • History of scar formation.
  • Patients with systemic diseases (diabetes, bleeding disorders, chronic renal diseases, chronic liver diseases, asthma and hypertension).
  • Patients who are receiving chemotherapy or radiotherapy.
  • Pregnant and lactating females.

研究组 & 干预措施

Microneedling + latanoprost

Active Comparator

patient will receive topical application of latanoprost 0.005% eye drops solution twice daily for 3 months preceded by microneeding in sessions by dermapen every 2 weeks for 3 months (totally 6 sessions).

干预措施: Latanoprost (Drug)

Microneedling + latanoprost

Active Comparator

patient will receive topical application of latanoprost 0.005% eye drops solution twice daily for 3 months preceded by microneeding in sessions by dermapen every 2 weeks for 3 months (totally 6 sessions).

干预措施: Microneedling (Device)

latanoprost

Active Comparator

Patient will receive topical application of latanoprost 0.005% eye drops solution only twice daily for 3 months (active control side).

干预措施: Latanoprost (Drug)

结局指标

主要结局

Improvement in VASI score

时间窗: 6 months

VASI score: The percentage of vitiligo involvement is calculated in terms of hand units. One hand unit is approximately equivalent to 1% of the total body surface area. The degree of pigmentation is estimated to the nearest of one of the following percentages: * 100% - complete depigmentation, no pigment is present * 90% - specks of pigment present * 75% - depigmented area exceeds the pigmented area * 50% - pigmented and depigmented areas are equal * 25% - pigmented area exceeds depigmented area * 10% - only specks of depigmentation present. The VASI for each body region is determined by the product of the area of vitiligo in hand units and the extent of depigmentation within each hand unit measured patch. Total body VASI = S All body sites \[Hand Units\] x \[Residual depigmentation\]. (Feily et al., 2014).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Noreen Ismail AbdelGhani Ahmed

resident at general administration of medical affairs

Sohag University

相似试验